NASDAQ 100
22.796,90
PKT
-421,22
PKT
-1,81
%
offiziell, realtime
22.962,50
USD
-402,50
USD
-1,72
%
future, verzögert
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.12 | The Kraft Heinz Company buy | UBS AG | |
| 18.01.12 | eBay neutral | Nomura | |
| 18.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 18.01.12 | Microsoft outperform | RBC Capital Markets | |
| 18.01.12 | Tesla overweight | Barclays Capital | |
| 18.01.12 | Tesla outperform | Robert W. Baird & Co. Incorporated | |
| 18.01.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 18.01.12 | Lululemon Athletica outperform | RBC Capital Markets | |
| 18.01.12 | Starbucks outperform | Williams Capital | |
| 18.01.12 | Alphabet A (ex Google) buy | Jefferies & Company Inc. | |
| 17.01.12 | Applied Materials outperform | RBC Capital Markets | |
| 17.01.12 | Honeywell neutral | UBS AG | |
| 17.01.12 | Linde neutral | J.P. Morgan Cazenove | |
| 16.01.12 | Booking overweight | JP Morgan Chase & Co. | |
| 16.01.12 | Amazon overweight | JP Morgan Chase & Co. | |
| 13.01.12 | Xcel Energy neutral | Robert W. Baird & Co. Incorporated | |
| 13.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 13.01.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.01.12 | Tesla overweight | Barclays Capital | |
| 13.01.12 | Biogen overweight | Barclays Capital | |
| 13.01.12 | Booking overweight | Piper Jaffray & Co. | |
| 12.01.12 | Linde neutral | Robert W. Baird & Co. Incorporated | |
| 12.01.12 | Intel outperform | Credit Suisse Group | |
| 12.01.12 | Linde buy | Citigroup Corp. | |
| 12.01.12 | Microsoft buy | UBS AG | |
| 12.01.12 | Apple buy | UBS AG | |
| 12.01.12 | Intel reduce | Nomura | |
| 12.01.12 | Starbucks kaufen | Aktienservice Research | |
| 11.01.12 | Linde buy | Commerzbank Corp. & Markets | |
| 11.01.12 | Microsoft buy | Nomura | |
| 11.01.12 | PepsiCo neutral | UBS AG | |
| 11.01.12 | QUALCOMM outperform | Oppenheimer & Co. Inc. | |
| 11.01.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 11.01.12 | The Kraft Heinz Company overweight | Barclays Capital | |
| 11.01.12 | Intel halten | Hamburger Sparkasse AG (Haspa) | |
| 10.01.12 | Linde buy | Sarasin Research | |
| 10.01.12 | Regeneron Pharmaceuticals outperform | Robert W. Baird & Co. Incorporated | |
| 10.01.12 | Amazon equal-weight | Barclays Capital | |
| 10.01.12 | Linde buy | Société Générale Group S.A. (SG) | |
| 10.01.12 | Adobe buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.